News
-
-
-
PRESS RELEASE
Original-Research: Antimony Resources Corp. (von GBC AG): BUY
GBC AG initiates coverage on Antimony Resources Corp., a key player in the antimony market due to its strategic deposits, with a BUY rating and target price of 3.00 CAD. Antimony's critical role in various industries makes it a promising investment option -
-
-
-
PRESS RELEASE
BioNxt Advances Semaglutide as First Application of Broad GLP-1 ODF Platform Strategy
BioNxt Solutions Inc. provides update on semaglutide ODF program and platform strategy. Focus on GLP-1 receptor agonists and peptide-based therapeutics. Potential market growth and commercial outlook discussed -
-
-